ANA-12
ANA-12
ANA-12 (pronounced A-N-A-Twelve) is a selective TrkB receptor antagonist. It is a small molecule that has been used in scientific research to study the role of the TrkB receptor in various biological processes.
Etymology
The term "ANA-12" does not have a known etymology. It is a name given to the compound by the researchers who first synthesized it.
Function
ANA-12 functions by binding to the TrkB receptor, a type of tyrosine kinase receptor. This binding prevents the activation of the receptor by its natural ligands, BDNF (Brain-Derived Neurotrophic Factor) and NT-4/5 (Neurotrophin-4/5). By blocking the activation of the TrkB receptor, ANA-12 can be used to study the effects of reduced TrkB signaling in various biological systems.
Use in Research
In research, ANA-12 has been used to study a variety of biological processes. These include neuronal survival, synaptic plasticity, and the development of certain types of cancer. By blocking TrkB signaling, researchers can investigate the role of this pathway in these processes.
Related Terms
- TrkB receptor: A type of tyrosine kinase receptor that is the target of ANA-12.
- BDNF: A natural ligand for the TrkB receptor.
- NT-4/5: Another natural ligand for the TrkB receptor.
- Neuronal survival: A process that is influenced by TrkB signaling.
- Synaptic plasticity: Another process that is influenced by TrkB signaling.
- Cancer: Certain types of cancer have been associated with abnormal TrkB signaling.
External links
- Medical encyclopedia article on ANA-12
- Wikipedia's article - ANA-12
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski